首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Current treatment options in neurology

缩写:CURR TREAT OPTION NE

ISSN:1092-8480

e-ISSN:1534-3138

IF/分区:1.3/Q4

文章目录 更多期刊信息

共收录本刊相关文章索引142条
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
L Jaap Kappelle L Jaap Kappelle
The risk of deep vein thrombosis (DVT) after stroke is increased in patients with restricted mobility, a previous history of DVT, dehydration, or comorbidities such as malignant diseases or clotting disorders. Patients with an increased ris...
William J Powers William J Powers
• Patients with acute ischemic stroke due to atherosclerotic carotid artery occlusion (ACAO) should receive intravenous tissue plasminogen activator (alteplase) if they meet eligibility criteria of the National Institute of Neurological Di...
Hannah C Glass,Sonia L Bonifacio,Thomas Shimotake et al. Hannah C Glass et al.
Neurocritical care is an emerging subspecialty that combines expertise in neurology, critical care medicine, neuroradiology, and neurosurgery. Increasing evidence from the adult literature suggests that specialized neurocritical care can le...
Lauren Baker,Rattan Juneja,Askiel Bruno Lauren Baker
There is considerable clinical evidence that hyperglycemia at the onset of acute ischemic stroke may negatively impact not only acute morbidity but also brain recovery. Establishing hyperglycemia treatment protocols is challenging, given th...
Simone L Ardern-Holmes,Kathryn N North Simone L Ardern-Holmes
Neurofibromatosis type 1 (NF1) and type 2 (NF2) are genetically and medically distinct neurocutaneous disorders that are both associated with tumors affecting the central and peripheral nervous systems. NF1 has a frequency of 1 in 3,000, co...
E Ann Yeh E Ann Yeh
Therapies for relapsing-remitting pediatric multiple sclerosis (MS) are aimed at preventing relapses (disease modifying therapies), treating acute attacks, and managing disabling cognitive and physical symptoms. Initial disease modifying th...
Mary Ann Thenganatt,Steven J Frucht Mary Ann Thenganatt
Sleep disturbance is an important feature of Parkinson's disease (PD) that deserves clinical attention. Various disorders need to be considered and treatment should be customized to the patient's specific symptoms and lifestyle. Evaluation ...
Ashok Krishnamoorthy,David Craufurd Ashok Krishnamoorthy
Apathy is one of the most prevalent neurobehavioral symptoms in Huntington's disease (HD), occurring in approximately 70% of the symptomatic HD population. Apathy scores in patients with HD are highly correlated with duration of illness, su...
Roop Kaw,Bhargavi Gali,Nancy A Collop Roop Kaw
It has been demonstrated that patients undergoing surgical procedures are at increased risk for complications if they have obstructive sleep apnea. It is believed that this increase in risk is related to more difficult intubations, use of v...
Nobuhide Hirai,Seiji Nishino Nobuhide Hirai
A diagnosis of narcolepsy requires pharmacologic treatment in more than 90% of patients. Wake-promoting compounds are used to treat excessive daytime sleepiness (EDS), and anticataplectics are used for cataplexy. The treatment of EDS includ...